These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9865373

  • 1. Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients.
    Cao S, Cox KL, Berquist W, So S, Concepcion W, Monge H, Esquivel CO.
    Transplant Proc; 1998 Dec; 30(8):4322-4. PubMed ID: 9865373
    [No Abstract] [Full Text] [Related]

  • 2. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
    Reggiani P, Rossi G, Latham L, Caccamo L, Gatti S, Maggi U, Melada E, Paone G, Doglia M, Vannelli A, Fassati LR.
    Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
    [No Abstract] [Full Text] [Related]

  • 3. Reduced acute rejection and side effects with neoral in liver transplantation.
    Tisone G, Vennarecci G, Pisani F, Baiocchi L, Mercadante E, Orlando G, Anselmo A, Casciani CU.
    Transplant Proc; 1998 Jun; 30(4):1430-1. PubMed ID: 9636579
    [No Abstract] [Full Text] [Related]

  • 4. Neoral as the initial immunosuppressant in liver transplantation; conversion from Sandimmune to Neoral in stable patients.
    Kizilisik AT, al-Sebayel M, Ramirez CB.
    Transplant Proc; 1998 Nov; 30(7):3537-8. PubMed ID: 9838549
    [No Abstract] [Full Text] [Related]

  • 5. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M, Rodeck B, Kardorff R, Hoyer PF, Maibücher A, Brodehl J.
    Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract] [Full Text] [Related]

  • 6. Low incidence of acute cellular rejection in liver transplantation with Neoral.
    Imventarza O, Lendoire J, Bianco G, Saúl J, Braslavsky G, Trigo P, Cueto G, Duek F, Aziz H.
    Transplant Proc; 1998 Aug; 30(5):1854. PubMed ID: 9723307
    [No Abstract] [Full Text] [Related]

  • 7. Results of conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients after two years.
    Dunn SP, Falkenstein K, Pierson A, Cooney GF.
    Transplant Proc; 1998 Aug; 30(5):1962-3. PubMed ID: 9723353
    [No Abstract] [Full Text] [Related]

  • 8. Potential role of Neoral in pediatric liver transplantation.
    Whitington PF, Alonso EM, Millis JM.
    Transplant Proc; 1996 Aug; 28(4):2267-9. PubMed ID: 8769221
    [No Abstract] [Full Text] [Related]

  • 9. Neoral without intravenous cyclosporine in liver transplantation.
    Hemming AW, Greig PD, Cattral MS, Chung SW, Lilly LB, Aljumah AA, Levy GA.
    Transplant Proc; 1997 Aug; 29(1-2):543. PubMed ID: 9123121
    [No Abstract] [Full Text] [Related]

  • 10. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
    Levy GA.
    Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216
    [No Abstract] [Full Text] [Related]

  • 11. Neoral versus Sandimmune in kidney transplantation.
    Tisone G, Orlando G, Mercadante E, Vennarecci G, Pisani F, Buonomo O, Negrini S, Casciani CU.
    Transplant Proc; 1998 Aug; 30(5):1749-50. PubMed ID: 9723265
    [No Abstract] [Full Text] [Related]

  • 12. Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients.
    Svendsen UG, Larsen KR, Allermand H, Thayssen P, Jensen SB, Pettersson G.
    Transplant Proc; 1996 Aug; 28(4):2281. PubMed ID: 8769225
    [No Abstract] [Full Text] [Related]

  • 13. Follow-up after conversion to Neoral in stable heart transplant recipients.
    Pethig K, Geiger M, Korn A, Grote M, Christians U, Wahlers T.
    Transplant Proc; 1996 Aug; 28(4):2282-4. PubMed ID: 8769226
    [No Abstract] [Full Text] [Related]

  • 14. Improvement in correlation between oral dose of cyclosporine and cyclosporinemia after substitution of conventional cyclosporine by Neoral cyclosporine in 296 liver transplant patients.
    Bilbao I, Parrilla P, Rimola A, Figueras J, Fabrega E, Gomez M, De Vicente E, Margarit C.
    Transplant Proc; 1998 Aug; 30(5):1833-7. PubMed ID: 9723300
    [No Abstract] [Full Text] [Related]

  • 15. Neoral in liver transplantation.
    Jamieson NV, Tan L, Jamieson I, Trull A, Gimson AE, Alexander G, Friend PJ, Calne RY.
    Transplant Proc; 1996 Aug; 28(4):2229-31. PubMed ID: 8769207
    [No Abstract] [Full Text] [Related]

  • 16. NOF-11: a one-year pediatric randomized double-blind comparison of neoral versus sandimmune in orthotopic liver transplantation.
    Alvarez F, Atkison PR, Grant DR, Guilbault N, Jones AB, Kim PS, Kneteman NM, Laurin L, Martin SR, Murphy GF, Paradis K, Shapiro J, Smith LJ, Superina RA.
    Transplantation; 2000 Jan 15; 69(1):87-92. PubMed ID: 10653385
    [Abstract] [Full Text] [Related]

  • 17. Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.
    Dibo-Cohen JM, Conort O, Conti F, Bernard D, Hazebroucq G, Calmus Y.
    Transplant Proc; 1998 Aug 15; 30(5):1857. PubMed ID: 9723309
    [No Abstract] [Full Text] [Related]

  • 18. A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral.
    Shah MB, Martin JE, Schroeder TJ, First MR.
    Transplant Proc; 1998 Dec 15; 30(8):4048-53. PubMed ID: 9865291
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients.
    Loss GE, Brady L, Grewal HP, Siegel CT, Mead J, Bruce DS, Cronin DC, Woodle ES, Newell KA, Thistlethwaite JR, Millis JM.
    Transplant Proc; 1998 Jun 15; 30(4):1435-6. PubMed ID: 9636581
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.